Logo
V

Veloxis Pharmaceuticals, Inc.

127 employees

Veloxis Pharmaceuticals, Inc., an Asahi Kasei company, is a fully integrated specialty pharmaceutical company committed to improving the lives of transplant patients. Headquartered in Cary, North Carolina, USA, Veloxis is focused on the global development and commercialization of medications utilized by transplant patients and by patients with serious related diseases. We know what transplant means to patients, and we’re leading innovation to improve their experience. For patients, transplant is a life-changing procedure. But changes come with challenges. At Veloxis, our mission is to see and respond to the challenges along the transplant journey. Read our Community Guidelines: https://bit.ly/3FQr7Wg

Investor insights

Funding rounds participated in

$60M sweet spot round size

Investor type

Public Company

Basic info

Industry

Biotechnology Research

Sectors

Biotechnology Research

Funding rounds raised

Total raised

$60M

from 1 investors over 1 rounds

V

Veloxis Pharmaceuticals, Inc. raised $60M on March 14, 2018

Investors: Athyrium Capital Management LP

FAQ